Iris.ai vs Consensus (2026)

Iris.ai

by Iris.ai

Consensus

by Consensus

Pros

• ✓Named enterprise adoption across Fortune 500 and government organizations: Mercedes-Benz, ArcelorMittal, USDA, Max Planck Gesellschaft, and Springer Nature appear on the official vendor homepage, providing procurement validation that is rare in the regulated enterprise AI infrastructure category.
• ✓Three-product architecture covers the full data-to-AI lifecycle: Axion handles data preparation into AI-ready intelligence, Neuralith powers the enterprise knowledge graph engine, and RSpace delivers precision R&D intelligence, providing end-to-end coverage that fragmented stacks requiring separate vendors for data preparation and AI agent deployment cannot match.
• ✓Ten-year track record from 2015 through multiple product pivots demonstrates operational maturity: the evolution from academic research AI through scientific language models to Agentic RAG-As-A-Services shows sustained development velocity and enterprise customer retention that AI challengers founded after 2020 cannot replicate.

Limitations

• ⚠No public independent review trail creates procurement friction: the G2 listing was removed in 2026, Trustpilot returns 404, and no Capterra presence exists, making third-party validation outside the vendor-provided homepage customer logos difficult; tools such as Elicit ($12/month) and SciSpace ($12/month) offer G2-verified reviews for procurement teams requiring independent evidence.
• ⚠Named integration depth is not published in official documentation: the Agentic RAG positioning implies enterprise data connectivity, but specific native integrations with SAP, Salesforce, Veeva Vault, SharePoint, PubMed, or Scopus are not confirmed, requiring sales-led scoping before integration depth can be evaluated.
• ⚠Enterprise-only entry with no self-serve evaluation path excludes individual researchers, academic teams, and smaller organizations: the platform requires sales-led engagement, custom data engineering, and sustained implementation investment with no trial access, while Elicit ($12/month) and SciSpace ($12/month) serve research use cases at a fraction of the cost and without implementation complexity.

Pros

• ✓Every answer cites real peer-reviewed papers with the Consensus Meter synthesizing agreement levels across studies into a plain-language verdict, eliminating the hallucination risk that makes general AI tools unreliable for academic, clinical, and policy research.
• ✓MCP server with 4.6M+ uses enables Claude, ChatGPT, and any MCP client to search 250M+ papers directly, making Consensus the most accessible academic evidence layer for AI agent workflows in the research category.
• ✓Institutional adoption at scale: 170+ university library partnerships (University of Michigan, Carnegie Mellon, Rice, Vanderbilt, McGill, Texas A&M, and more) plus licensed full-text content from Wiley, Taylor and Francis, Sage, ACS, and APA provide publisher-grade depth beyond abstract-only search.

Limitations

• ⚠Academic literature only with no web, news, or non-peer-reviewed source coverage: users needing open web research must pair Consensus with Perplexity AI ($20/month) or ChatGPT Deep Research ($20/month) for cross-domain questions that extend beyond the academic corpus.
• ⚠Deep review tier at $45/month represents a significant price jump from Pro at $10/month: researchers conducting frequent comprehensive literature reviews across 50+ papers face a 4.5x cost increase, while SciSpace ($12/month) and Elicit ($12/month) offer systematic review tools at lower entry points.
• ⚠No third-party security certifications published: despite strong privacy practices (no data training, anonymized usage, custom data handling options), the absence of SOC 2 or GDPR certification may create procurement friction at institutions requiring formal compliance documentation.